NCT04677062View on ClinicalTrials.gov

Safety, Galenic Acceptability and Efficacy of GV-328 Lozenges in Children With Oral Aphthosis

NACompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

November 1, 2017

Primary Completion Date

June 30, 2019

Study Completion Date

June 30, 2019

Conditions
Aphthous Stomatitis
Interventions
DRUG

GV-328

Patients with GV-328 treatment

Trial Locations (1)

08195

Universitat Internacional de Catalunya, Sant Cugat del Vallès

All Listed Sponsors
lead

Universitat Internacional de Catalunya

OTHER

NCT04677062 - Safety, Galenic Acceptability and Efficacy of GV-328 Lozenges in Children With Oral Aphthosis | Biotech Hunter | Biotech Hunter